Skip to main content
Clinical Trials/CTRI/2014/09/005040
CTRI/2014/09/005040
Recruiting
未知

Comparative study of visual outcome between femtosecond lasik with excimer laser and all femtosecond ReLEx small incision lenticule extraction(SmILE)

ethradhama Superspeciality Eye Hospital0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Healthy Patients with Short Sightedness
Sponsor
ethradhama Superspeciality Eye Hospital
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ethradhama Superspeciality Eye Hospital

Eligibility Criteria

Inclusion Criteria

  • SINGLE SURGEON
  • MYOPIA BETWEEN 1D TO 10D SPHERICAL EQUIVALENT/AMOUNT OF ASTIGMATISM LESS THAN 5D
  • AGE ABOVE 21 YEARS AND LESS THAN 40 YEARS.
  • STABLE REFRACTION FOR ATLEAST 6MNTHS\- 1 YEAR
  • SOFT CONTACT LENS DISCONTINUED FOR MINIMUM 1 WEEK AND RIGID GAS PERMEABLE CONTACT LENS DISCONTINUED FOR MINIMUM 3 WEEKS
  • CORNEAL TOPOGRAPHY\-MINIMUM CORNEAL THICKNESS 480µ, RESIDUAL CORNEAL THICKNESS ATLEAST 250µ/50% OF ORIGINAL THICKNESS (WHICHEVER IS HIGHER)

Exclusion Criteria

  • EVIDENCE OF OCULAR DISEASES LIKE MEIBOMIAN GLAND DISEASES, HERPETIC KERATITIS, UVIETIS, GLAUCOMA, VISUALLY SIGNIFICANT CATARACT, RETINAL DISEASES LIKE RETINAL DYSTROPHIES OR DIABETIC RETINOPATHY.
  • PROGRESSIVE/UNSTABLE MYOPIA AND/OR ASTIGMATISM
  • ANY PATHOLOGIES OF CORNEA LIKE CORNEAL DYSTROPHIES INCLUDING KERATOCONUS,ANY H/O CORNEAL TRAUMA OR SURGERY WITHIN FLAP ZONE
  • DRY EYE STATUS\-SCHIRMERâ??S 2 TEST VALUE LESS THAN 10 mm
  • OCULAR MEDICATION LIKE β BLOCKERS.
  • TAKING ANY SYSTEMIC MEDICATION LIKELY TO AFFECT WOUND HEALING LIKE CORTICOSTEROIDS OR ANTIMETABOLITES.
  • H/O IMMUNOCOMPROMISED STATE OR PREGNANCY OR NURSING MOTHERS

Outcomes

Primary Outcomes

Not specified

Similar Trials